We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · August 17, 2020

APEX: A Phase 2 RCT Evaluating the Use of Oral X-82 for Exudative AMD

The British Journal of Ophthalmology


Additional Info

The British Journal of Ophthalmology
APEX: A Phase II Randomised Clinical Trial Evaluating the Safety and Preliminary Efficacy of Oral X-82 to Treat Exudative Age-Related Macular Degeneration
Br J Ophthalmol 2020 Jun 25;[EPub Ahead of Print], MN Cohen, D O'Shaughnessy, K Fisher, J Cerami, CC Awh, DE Salazar, P Rosenfeld, JS Heier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading